The Cure Parkinson's Trust (CPT) is pleased to announce two new additions to its Research Committee: Dr Heather Mortiboys and Dr Kevin McFarthing.

Dr Heather Mortiboys is Senior Lecturer/Senior Research Fellow at Sheffield University, where her primary focus is mitochondria in neurodegenerative diseases, particularly Parkinson’s. This encompasses mitochondrial function, DNA, morphology and recycling. Her research focuses on both trying to further the understanding of the causes of mitochondrial problems in neurodegenerative conditions and in vitro drug screening for molecules which rescue mitochondrial function in patient tissue. Heather said:

"It's an honour to join the Research Committee at The Cure Parkinson's Trust. I am very much looking forward to contributing to CPT's goal of accelerating research for a cure."

Originally a biochemist, Dr Kevin McFarthing spent most of his career leading R&D groups in life sciences (Amersham), diagnostics (Serono) and consumer health (Reckitt Benckiser). He now runs the Innovation Fixer consultancy and was voted the #1 blogger on innovation in 2015. He was diagnosed with Parkinson’s in 2012. Kevin has created the Hope List, a database of current therapies in development for Parkinson's. Kevin said:

"I’m delighted to join the Research Committee of The Cure Parkinson’s Trust and to be able to make a small contribution to the search for a cure."

Helen Matthews, Deputy CEO of CPT said:

"We are delighted that Kevin and Heather have joined the CPT Research Committee. This committee evaluates research funding applications for the charity, and following peer review, makes informed recommendations to trustees in line with AMRC best practice."

 Read more about the Research Committee here.